Metixene

Metixene (brand names Methixart, CholinFall, Tremonil, Trest), also known as methixene, is an anticholinergic used as an antiparkinsonian agent.^[2] It has also been reported to induce incomplete autophagy and cell death in metastatic cancer and brain metastases. ^[3]

Metixene

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	N04AA03 (WHO)
Legal status
Legal status	BR: Class C1 (Other controlled substances)[1]
Identifiers
IUPAC name 1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine
CAS Number	4969-02-2 Y
PubChem CID	4167
IUPHAR/BPS	7232
DrugBank	DB00340
ChemSpider	4023
UNII	32VY6L26ZW
KEGG	D08209
ChEBI	CHEBI:51024
ChEMBL	ChEMBL1201342
CompTox Dashboard (EPA)	DTXSID1047867
ECHA InfoCard	100.023.282
Chemical and physical data
Formula	C20H23NS
Molar mass	309.47 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN1CCCC(C1)CC2C3=CC=CC=C3SC4=CC=CC=C24
InChI InChI=1S/C20H23NS/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20/h2-5,8-11,15,18H,6-7,12-14H2,1H3 Key:MJFJKKXQDNNUJF-UHFFFAOYSA-N
NY (what is this?)  (verify)

See also

• 3-Quinuclidinyl thiochromane-4-carboxylate
• Dothiepin